- Home
- / ABL Bio
ABL Bio
Total Funding
$90.8 M
ABL Bio Summary
Company Summary
- Overview
- ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. It offers a range of bispecific antibody platforms.
- Type
- Private
- Status
- Active
- Founded
- 2016
- Website
- https://www.ablbio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025